A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
Seagen Inc.
Seagen Inc.
Compass Therapeutics
Travera Inc
7 Hills Pharma, LLC
KaliVir Immunotherapeutics
iOnctura
Sotio Biotech Inc.
M.D. Anderson Cancer Center
Ohio State University
Endeavor Biomedicines, Inc.
Azienda Ospedaliero-Universitaria di Parma
St. Jude Children's Research Hospital
University of Nebraska
Novartis
Kezar Life Sciences, Inc.
NeoTX Therapeutics Ltd.
HiFiBiO Therapeutics
Seattle Children's Hospital
Actym Therapeutics, Inc.
Incyte Corporation
Numab Therapeutics AG
NuCana plc
Azienda Ospedaliera di Padova
Medicenna Therapeutics, Inc.
Turnstone Biologics, Corp.
SOLTI Breast Cancer Research Group
Checkpoint Therapeutics, Inc.
BerGenBio ASA
Aminex Therapeutics, Inc.
Taproot Health
Molecular Templates, Inc.
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
University of California, San Diego
Pfizer
Memorial Sloan Kettering Cancer Center
NGM Biopharmaceuticals, Inc
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Rain Oncology Inc
Western Sydney Local Health District
Seagen Inc.
Jules Bordet Institute
Quadriga Biosciences, Inc.
Xencor, Inc.
Incyte Corporation
AbbVie
Infinity Pharmaceuticals, Inc.
Novartis
MacroGenics